Moreover, lncRNA NORAD enhances pancreatic cancer metastasis through promoting epithelial–mesenchymal transition via targeting hsa-miR-125a-3p to increase RhoA expression (Li et al., 2017). Here, RHOA is linked to familial pancreatic carcinoma.